Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (1870)

Name Institution Why
Kenneth Carl Anderson, M.D.Dana-Farber Cancer Institute Why?
Paul Edward Sax, M.D.Brigham and Women's Hospital Why?
Paul Gerard Guy Richardson, M.B.,B.S.Dana-Farber Cancer Institute Why?
Charles Allen Boucher, M.D.Massachusetts General Hospital Why?
Teru Hideshima, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Raymond Taeyong Chung, M.D.Massachusetts General Hospital Why?
Dharminder Chauhan, Ph.D., J.D.Dana-Farber Cancer Institute Why?
Daniel Robert Kuritzkes, M.D.Brigham and Women's Hospital Why?
Steven Kyle Grinspoon, M.D.Massachusetts General Hospital Why?
Michael David Hughes, Ph.D.Harvard T.H. Chan School of Public Health Why?
Alfred Lewis Goldberg, Ph.D.Harvard Medical School Why?
Sylvie Le Gall, Ph.D.Massachusetts General Hospital Why?
Scott David Solomon, M.D.Brigham and Women's Hospital Why?
Mary Alexandra Albrecht, M.D.Beth Israel Deaconess Medical Center Why?
Kenneth Hugh Mayer, M.D.Other Why?
Per Page    Page  of 125last Nextnext
Search Criteria
  • Protease Inhibitors
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.